InsidersTradesSigma
申报总数
公司
▲ 买入（2 笔）
▼ 卖出（0 笔）
内部人交易记录
高级管理人员已披露买入
2
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Browse the detailed record of transactions filed by Kenney Richard T, Directeur Médical. Officer active across 2 companies, notably Sonnet BioTherapeutics Holdings, Inc.. In total, 8 reports have been published. Split: 2 buys · 0 sell. Total volume traded: €32k. History available since 19 May 2021. The latest transaction was filed on 9 June 2021 (Acquisition). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Kenney Richard T
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报8 总计
9,374 股Common StockSEC:0001493152-25-026217:0
8,000 股Common StockSEC:0001641172-25-019781:0
1,271 股Common StockSEC:0001493152-24-048953:0
14,627 股Common StockSEC:0001493152-23-005469:0
14,627 股Common StockSEC:0001493152-22-036312:0
15,000 股@ US$1.5459.8% 占其流量Common StockSEC:0001493152-21-013939:0
标准退出：2021年9月7日 (T+90)
10,000 股@ US$1.5540.2% 占其流量Common StockSEC:0000905718-21-000714:0
标准退出：2021年8月17日 (T+90)
7,000 股Common StockSEC:0001123292-16-001535:0
8 条申报中的 8 条
About Kenney Richard T
Richard T. Kenney is the Chief Medical Officer at Sonnet BioTherapeutics Holdings, Inc. He oversees the company's medical and research initiatives, contributing to its development in the biopharmaceutical sector.
